Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2009-06-22
2010-10-26
Desai, Anand U (Department: 1656)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C435S320100, C435S476000, C435S069100, C435S490000
Reexamination Certificate
active
07820806
ABSTRACT:
Methods for producing membrane-spanning polypeptides in high yields, with native conformation, and/or in soluble form include solubilizing in non-ionic or zwitterionic detergents, as well as use of promoters and expression vectors for expressing high yields of membrane-spanning polypeptides in bacterial cells. Mutated promoters provide tight control of membrane-spanning polypeptides in bacterial cell hosts.
REFERENCES:
patent: 4738921 (1988-04-01), Belagaje et al.
patent: 5013653 (1991-05-01), Huston et al.
patent: 6242177 (2001-06-01), Simmons et al.
patent: 6537779 (2003-03-01), Kara et al.
patent: 6808925 (2004-10-01), Calos
patent: 7247426 (2007-07-01), Yakhini et al.
patent: 7691989 (2010-04-01), Ernst et al.
patent: 2003/0148457 (2003-08-01), Kinrade et al.
patent: 2003/0228326 (2003-12-01), Palomba et al.
patent: 2006/0172385 (2006-08-01), Ernst et al.
patent: 2010/0081170 (2010-04-01), Ernst et al.
patent: 0 300 425 (1989-01-01), None
patent: 0 300 425 (1989-01-01), None
patent: 0 303 925 (1989-02-01), None
patent: 03-123486 (1991-05-01), None
patent: WO-97/21829 (1997-06-01), None
patent: WO-99/53033 (1999-10-01), None
patent: WO-01/09189 (2001-02-01), None
patent: WO-01/09189 (2001-02-01), None
patent: WO-01/14407 (2001-03-01), None
patent: WO-01/14407 (2001-03-01), None
patent: WO-01/55176 (2001-08-01), None
patent: WO-01/55176 (2001-08-01), None
patent: WO-01/74903 (2001-10-01), None
patent: WO-01/74903 (2001-10-01), None
patent: WO-01/98453 (2001-12-01), None
patent: WO-01/98453 (2001-12-01), None
patent: WO-2006/069403 (2006-06-01), None
patent: WO-2006/069403 (2006-06-01), None
Backert, S. et al. (1998), “Microcorrespondence: Potential Role of TwoHelicobacter pyloriRelaxases in DNA Transfer?”Mol. Microbiol.30(3):673-678.
Bell, C. E. et al. (2000). “A Closer View of the Conformation of the Lac Repressor Bound to Operator,”Nat. Struct. Biol.7(3):209-214.
Chevalet, L. et al. (2000). “Recombinant Protein Production Driven by the Tryptophan Promoter is Tightly Controled in ICONE 200, a New Genetically EngineeredE. coliMutant,”Biotechnol. Bioeng.69(4):351-358.
Database JPO Proteins [Online ], EBI Accession No. JPOP:E50448, Jul. 1, 1997.
Dombrowicz, D. et al. (Apr. 1998). “Allergy-Associated FcRbeta is a Molecular Amplifier of IgE- and IgG-mediated in vivo Responses,”Immunity8(4);517-529.
Donato, J.L. et al. (Jan. 2002). “Human HTm4 is a Hematopoietic Cell Cycle Regulator,”J. Clin. Invest.109(1):51-58.
Ernst, J.A. et al. (2005). “Isolation and Characterization of the B-cell Marker CD20,”Biochemistry44(46):15150-15158.
Hersh, D. et al. (1999). “TheSalmonellainvasin SipB Induces Macrophage Apoptosis by Binding to Caspase-1,”Proc. Natl. Acad. Sci. USA96(5):2396-2401.
Huez, I. et al. (1998). “Two Independent Internal Ribosome Entry Sites are Involved in Translation Intiation of Vascular Endothelial Growth Factor mRNA,”Mol. Cell. Biol.18(11):6178-6190.
International Search Report for PCT/US2005/047653, mailed on Aug. 1, 2006, 9 pages.
INVITROGEN. (2008 updated). Vector Backbone: pCR3.1, located at <www.addgene.org/pgvec1?=c&cmd=shovecinfo&vectorid=6620&pf=true,> pp. 1-3.
INVITROGEN. (2008, updated). “pcDNA 3.1”Intvitrogen Life TechnologyCatalog Nos. V790-20 and V795-20, p. 9.
Ishibashi, K. et al. (Feb. 7, 2001). “Identification of a New Multigene Four-Transmembrane Family (MS4A) Related to CD20, HTm4 and Beta Subunit of the High-Affinity IgE Receptor,”Gene264(1):87-93.
Kinet, J.P. (1999). “The High-affinity IgE Receptor (Fc epsilon RI): From Physiology to Pathology,”Annu. Rev. Immunol.17:931-972.
Liang, Y. et al. (Mar. 1, 2001). “Identification of a CD20-, FcepsilonRIbeta-, and HTm4-related Gene Family: Sixteen New MS4A Family Members Expressed in Human and Mouse,”Genomics72(2):119-127.
Lin, S. et al. (Jun. 28, 1996). “Fc(epsilon)RIbeta Subunit Functions as an Amplifier of Fc(epsilon)RIgamma-mediated Cell Activation Signals,”Cell85(7):985-995.
Naider, F. et al. (2001). “Peptide Fragments as Models to Study the Structure of a G-Protein Coupled Receptor: The Alpha-Factor Receptor ofSaccharomyces cerevisiae,” Biopolymers60(5):334-350.
Polyak, M.J. et al. (Oct. 1, 1998). “Identification of a Cytoplasmic Region of CD20 Required for its Redistribution to a Detergent-insoluble Membrane Compartment.”Journal of Immunology161(7):3242-3248.
Ruberg, S. et al. (1999). “Biosynthesis of the Expolsaccharide galactoglucan inSinorhizobium melilotiis Subject to a Complex Control by the Phosphate-Dependent Regulator PhoB and the Proteins ExpG and MucR,”Microbiology145(3):603-611.
Saxena, P. et al. (1992). “Expression of argU, theEscherichia coliGene Coding for a Rare Arginine tRNA,”J. Bacteriol.174(6):1956-1964.
Stashenko, P. et al. (Oct. 1980). “Characterization of a Human B Lymphocyte-specific Antigen,”J. Immunology125(4):1678-1685.
Stenstrom, C.M. et al. (2002). “Influences on Translation Initiation and Early Elongation by the Messenger RNA Region Flanking the Initiation Codon at the 3′ Side,”Gene288(1/2):1-8.
Taylor, C.M. et al. (Jul. 2003). “Enhanced Resolution of Glycosylphosphatidylinositol-Anchored and Transmembrane Proetins from the Lipid-rish Myelin Membrane by Two-dimensional Gel Electrophoresis,” Proteomics 3(7):1303-1312.
Written Opinion of the International Searching Authority for PCT/US2005/047653, mailed on Aug. 1, 2006, 17 pages.
Xie, X-Q. et al. (Nov. 20004). “Expression, Purification, and Isotope Labeling of Cannabinoid CB2 Receptor Fragment, CB2(180-233),”Protein Expr. Purif.38(1):61-68.
Glick, B.R. et al. (2002).Molecular Biotechnology, Principles and Applications,American Society of Microbiology, (Original document in Russian language, English Translation of pp. 365-367.)
Guzman, L-M. et al. (Jul. 1995). “Tight Regulation, Modulation, and High-Level Expression by Vectors Containing the Arabinose PBADPromoter,”Journal of Bacteriology177(14):4121-4130.
Maniatis, T. et al. (1982), “Vectors That Express Cloned DNA inEscherichia coli,” Chapter 12in Molecular Cloning: A Laboratory Manual,Cold Spring Harbor Laboratory: New York, NY, pp. 403-433 (with Table of Contents.)
Maniatis, T. et al. (1984).Molecular Cloning: A Laboratory Manual,Cold Spring Harbor Laboratory: New York, NY, (Original document in Russian language, p. 360, 361, 364, 383, 385 corresponds with Maniatis 1982 Chapter 12 above.).
Patrushev, L.I. (2004).Iskusstvennye Geneticheskie Sistemy(Artificial Genetic Systems), Moscow, Nauka, (Original document in Russian language, English Translation of 1:108, 111-112.).
Rybchin, V.N. (2002). “Osnovy Geneticheskoi Indgenerii” (Foundations of Genetic Engineering), St. Petersburg, SPbGTU Publ. (Original document in Russian language pp. 317, 329, 339; English Translation two pages.).
Ernst James A.
Kim Hok Seon
Yansura Daniel
Desai Anand U
Genentech Inc.
Liu Samuel
Morrison & Foerster / LLP
LandOfFree
Methods for producing soluble membrane spanning proteins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for producing soluble membrane spanning proteins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for producing soluble membrane spanning proteins will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4174542